Female hormones affect symptom severity in obsessive-compulsive disorder

International Clinical Psychopharmacology

Volumn 21, Issue 3, 2006, Pages 171-175

  Vulink, Nienke C C ^a,b   Denys, Damiaan ^a   Bus, Léonie ^a   Westenberg, Herman G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Gonadal steroids; Obsessive compulsive disorder; Premenstrual dysphoric disorder; Reproductive events

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; CONTRACEPTIVE AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE;

ADULT; ARTICLE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUERPERAL DEPRESSION; QUESTIONNAIRE; RATING SCALE; SELF REPORT; SYMPTOMATOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CLOMIPRAMINE; CONTRACEPTIVES, ORAL, HORMONAL; DEPRESSION, POSTPARTUM; DRUG THERAPY, COMBINATION; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PREGNANCY; PREMENSTRUAL SYNDROME; QUESTIONNAIRES; RECURRENCE; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; WITHHOLDING TREATMENT;

EID: 33646677948     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yic.0000199454.62423.99     Document Type: Article

References (34)

1. Abramowitz J, Moore K, Carmin C, Wiegartz PS, Purdon C (2001). Acute onset of obsessive-compulsive disorder in males following childbirth. Psychosomatics 42:429-431.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association Press.
3. Baer L, Brown-Beasley MW, Sorce J, Henriques AI (1993). Computer-assisted telephone administration of a structured interview for obsessive-compulsive disorder. Am J Psychiatry 150:1737-1738.
4. Becker JB (1999). Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64:803-812.
5. Buttolph ML, Holland AD (1990). Obsessive compulsive disoders in pregnancy and childbirth. In: Jenike A, Bear L, Minichiello WE, editors. Obsessive-compulsive disorders: theory and treatment, vol. 2. Chicago: Mosby pp. 89-95.
6. Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL (2003). Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 160:1519-1522.
7. Denys D, Zohar J, Westenberg HG (2004a). The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 65 (suppl 14):11-17.
8. Denys D, Van Der Wee WN, Janssen J, De Geus F, Westenberg HG (2004b). Low level of dopaminergic D(2) receptor binding in obsessive-compulsive disorder. Biol Psychiatry 55:1041-1045.
9. Gardiner SA, Morrison MF, Mozley PD, Mozley LH, Brensinger C, Bilker W, et al. (2004). Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women. Am J Geriatr Psychiatry 12:621-630.
10. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. (1989a). The Yale-Brown obsessive compulsive scale. II. Validity. Arch Gen Psychiatry 46:1012-1016.
11. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. (1989b). The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011.
12. Goodwin DW, Guze SB, Robins E (1969). Follow-up studies in obsessional neurosis. Arch Gen Psychiatry 20:182-187.
13. Joffe H, Cohen LS, Harlow BL (2003). Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration. Am J Obstet Gynecol 189:1523-1530.
14. McLeod DR, Hoehn-Saric R, Foster GV, Hipsley PA (1993). The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psychiatr Scand 88:248-251.
15. Labad J, Menchon JM, Alonso P, Segalas C, Jimenez S, Vallejo J (2005). Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 66:428-435.
16. Levesque D, Di Paolo T (1988). Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci Lett 88:113-118.
17. Oinonen KA, Mazmanian D (2002). To what extent do oral contraceptives influence mood and affect? J Affect Disord 70:229-240.
18. Rasmussen SA, Eisen JL (1991). Phenomenology of OCD: clinical subtypes, heterogeneity and coexistence. In: Zohar J, Insel TR, Rasmussen S, editors. The psychobiology of obsessive-compulsive disorder. New York: Springer. pp. 13-43.
19. Sabin R, Slade P (1999). Reconceptualizing premenstrual emotinal symptoms as phasic differential responsiveness to stressors. J Reproduct Infant Psychol 17:381-390.
20. Sasson Y, Zohar J, Chopra M, Lustig M, lancu I, Hendler T (1997). Epidemiology of obsessive-compulsive disorder: a world view. J Clin Psychiatry 58 (suppl 12):7-10.
21. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs. J, Weiller E, et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (suppl 20):22-33.
22. Sichel DA, Cohen LS, Dimmock JA, Rosenbaum JF (1993). Postpartum obsessive compulsive disorder: a case series. J Clin Psychiatry 54:156-159.
23. Sigmon ST, Dorhofer DM, Rohan KJ, Hotovy LA, Boulard NE, Fink CM (2000). Psychophysiological, somatic, and affective changes across the menstrual cycle in women with panic disorder. J Consult Clin Psychol 68:425-431.
24. Skoog G, Skoog I (1999). A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 56:121-127.
25. Soares CN, Almeida OP, Joffe H, Cohen LS (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529-534.
26. Steketee G, Frost R, Bogart K (1996). The Yale-Brown Obsessive Compulsive Scale: interview versus self-report. Behav Res Ther 34:675-684.
27. Thompson TL (1999). Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Res 834:164-167.
28. 123I]beta-CIT SPECT. Am J Psychiatry 161:2201-2206.
29. Vulink NC, Denys D, Westenberg HG (2005). Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. J Clin Psychiatry 66:228-230.
30. Williams KE, Koran LM (1997). Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 58:330-334.
31. Wisner KL, Peindl KS, Gigliotti T, Hanusa BH (1999). Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 60:176-180.
32. World Health Organization Scientific Group {1996). Research on the menopause in the 1990s. World Health Organization technical services department series no. 866. Geneva: World Health Organization.
33. Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D (2000). Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 1:92-100.
34. Zohar J, Kennedy JL, Hollander E, Koran LM (2004). Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. J Clin Psychiatry 65 (suppl 14):18-21.